Introduction
Monoclonal antibody PAb1620 recognizes a conformational epitope on transcription factor p53 (Milner et al., 1987) . Additionally, this antibody allosterically inhibits wild-type p53 binding to DNA , and has been used extensively to characterize mutant forms of p53 (Halazonetis and Kandil, 1993; and p53 molecules isolated from tumors and transformed cell lines (Niewolik et al., 1995) .
Because of p53's critical roles in cell-cycle progression and apoptosis, both resulting from p53-DNA binding interactions (reviewed in Levine, 1997) which can be allosterically regulated by PAb1620 , an eort was undertaken to identify the conformational epitope on wild-type p53 that interacts with PAb1620. Identi®cation of this epitope would help to elucidate the mechanism by which PAb1620 regulates p53-DNA interactions, and also could contribute to greater understanding of the conformational changes that p53 undergoes when binding to DNA.
Epitope characterization has been done for numerous antibodies which recognize linear peptide sequences. Much of this work used arrays of overlapping synthetic peptides (Houghten, 1985; Appel et al., 1990; Pinilla et al., 1993) or proteolyzed fragments of the natural antigen (Ellgaard et al., 1995) . Libraries of phagedisplayed peptides, some of which contained relatively short peptides (420 amino acids) (Scott and Smith, 1990; Stephen and Lane, 1992; Renschler et al., 1994; Stephen et al., 1995) and others that contained longer peptides (420 amino acids) (Kay et al., 1993; Grihalde et al., 1995; Chen et al., 1996) have been used as alternative sources of epitopes. These phage libraries were all tested against antibodies recognizing continuous or discontinuous linear epitopes.
For this study, classical epitope mapping strategies such as the use of overlapping synthetic peptides or proteolytic fragments of p53 were avoided for two main reasons. The ®rst of these is that PAb1620 is conformationally sensitive such that even single amino acid substitutions in human p53 can negatively aect binding (Milner and Medcalf, 1990; Niewolik et al., 1995) . The second reason is that wild-type p53 is known to assume dierent conformations, not all of which are recognized by PAb1620 Hall and Milner, 1995) . For these reasons, it was believed that synthetic peptides or proteolytic fragments of p53 would most likely not adopt a conformation recognized by PAb1620.
A highly diverse (1.5610 10 members) phage-displayed library of random 40 amino acid peptides was made in an eort to produce peptides with a greater probability of having complex protein-like conformational surfaces . Panning of this library against PAb1620 resulted in the isolation of three distinct clones, all of which appear to bind speci®cally to a single overlapping site on PAb1620 as judged by competition analysis. Sequence comparison of the peptides with p53 allowed the mapping of the epitope to amino acid residues not contained within the DNA binding domain. This epitope includes amino acids that are spatially close in the crystal structure of p53, but far removed from each other in the linear sequence.
Results

Construction of the peptide library
A degenerate template was synthesized to code for 40 random amino acids and was ampli®ed as described in Materials and methods. The random codons are encoded by the sequence NNK, where N=G, A, T, or C, and K=T or G. The NNK design codes for all 20 amino acids, and eliminates the TGA and TAA stop codons, but not the TAG stop codon. The peptides were designed to carry the Flag epitope (DYKD) (Hopp et al., 1988) at their amino termini, and the E-tag epitope (GAPVPYPDPLEPR) at their carboxyl termini (Figure 1 ). The peptides are expressed as gene III protein fusions using the phagemid vector pCANTAB5E (Pharmacia Biotech). Five cell sublibraries were generated and combined. Together, they comprise a library of 1.5610 10 members. A more detailed analysis of this library has been published elsewhere .
Panning and selection of peptide binders
Three rounds of panning were carried out as described in Materials and methods. Phage titers were determined for the last wash and subsequent acid elution for each round. The results (Figure 2) show a large increase in elution titer in the third round. Eluted phage from each round were ampli®ed and tested by ELISA (Enzyme-Linked Immunosorbent Assay) for binding to PAb1620 and a control monoclonal antibody. Figure 2 shows that while a slight increase in signal was seen with phage from Round 2, a large increase was seen with phage from Round 3.
Twenty-four individual clones were picked from both Round 2 and Round 3 elutions. Phage were prepared from each clone and tested by ELISA for the presence of E-tag and the ability to bind to PAb1620. Table 1 summarizes the results. No target-positive clones were identi®ed in Round 2, and a total of six target-positive clones were identi®ed in Round 3. As shown, approximately half of the isolated E-tag positive clones from Round 3 were also positive for PAb1620. All of these showed speci®c binding when compared to control wells (Figure 3 ).
Sequence determinations and analyses
Three dierent phage clones (Clones 13, 16 and W) were obtained from two separate biopanning experiments. All three clones bind speci®cally to the PAb1620 antibody as determined by ELISA ( Figure  3 ). The most abundant clone was Clone 13, with four copies identi®ed in the panning experiment; two copies of Clone 16 were found; and only one copy of Clone W was isolated.
The sequences of the peptides predicted by translating the ORFs (open reading frames) were compared to the 219 residue sequence of the core region of p53 (residues 94 ± 312) (Figure 4) . A ®ve out of six residue (5/6) identity was recognized between amino acids 146 ± 151 of p53 and Clone 16. The likelihood of a fortuitous 5/6 match between two Figure 1 Schematics for the phage library construction. The sequence of the pCANTAB5E phagemid in the vicinity of S®I and NotI sites is shown together with the sequence of the signal peptide, linker and the E-tag peptide. The DNA sequences of the oligonucleotides used to construct the randomized DNA fragment are shown above the pCANTAB5E sequence. Sequence to the left of thin vertical line is found in the ®nal library construction Gray: Signal from binding to immobilized anti-E-tag MAb. Phage inputs for this assay were all approximately 10 11 c.f.u./ml. The assay was done as described in Materials and methods sequences of 219 and 23 amino acids is 0.006 according to a previously published formula (Chen et al., 1996) , indicating a signi®cant match. Given that a region of sequence similarity has been identi®ed (residues 146 ± 156 of p53), the likelihood that another peptide of 27 residues (Clone 13) will show a 4/11 match (allowing for an insertion of one residue) can be estimated at about 0.06. In summary, the likelihood that the alignment shown in Figure 4a re¯ects a true sequence homology and not a fortuitous sequence match between p53 and two other short random sequences can be estimated as greater than 0.9996 (a product of the two probabilities).
Once the alignment in Figure 4a was identi®ed, the residues in close spatial proximity to the 146 ± 156 region of p53 were examined in the available crystal structure of the p53-DNA complex (PDB Accession No. 1TUP). A group of about 30 residues was further studied for homologies with the three clones. Two clones (Clone 16 and Clone W) showed a 4/8 match with residues 106 ± 113 of p53 (Figure 4b). Since the probability of a fortuitous 4/8 match for one clone is 0.08, the probability that two clones will show the same fortuitous alignment is equal to the square of the probability for one clone (i.e. 0.006). In summary, the probability that the alignment shown in Figure 4b re¯ects a true sequence homology, considering the alignment shown in Figure 4a , can be estimated as greater than 0.99.
The p53 binding site for the PAb1620 antibody (Figure 4 ) is, therefore, composed of two parts of the p53 polypeptide chain, namely residues 106 ± 113 and 146 ± 156. The ®rst region comprises residues from the S1 strand (110 ± 112) (Cho et al., 1994) and the surrounding four residues (106 ± 109 and 113). The second region, which is roughly anti-parallel to the ®rst, forms an extended loop connecting strands S3 and S4, and contains one residue from each of the two strands (Trp146 from strand S3 and Arg156 from strand S4). The largest distance between the Ca atoms within this binding site is 24.6 A Ê (between residues Phe113 and Pro153) which is compatible with the dimensions of a typical antibody binding site (30 A Ê ). The most exposed surface residues within the identi®ed PAb1620 binding site are Ser106, Asp148, Thr150 and Pro153, all with relative surface exposed areas more than 50% of the maximal value for the given amino acid residue (determined by the program ACCALL on the PDB entry 1TUP).
Determination of binding characteristics
The deduced peptide encoded by Clone 13 was synthesized as a soluble peptide, then competed against the phage-bound forms of Clone 13, Clone 16, and Clone W. The results ( Figure 5) show that the Clone 13 peptide has an IC 50 =2 ± 4 mM, and competes all three phage-bound peptides equally. Although Clone W has less sequence identity with p53 than either of the two other peptides, the fact that it is competed in a similar manner indicates that it binds to an overlapping surface on PAb1620.
Determination of the K D for the synthetic form of Clone 13 was also performed using a BIAcore X (Biosensor), giving an averaged apparent K D of 3.5 mM (data not shown), which is essentially identical to the IC 50 value determined by competition.
Discussion
In this paper, we have completed the initial characterization of the epitope for the monoclonal antibody PAb1620 (anti-p53). This antibody recognizes a conformational epitope on wild-type p53, which is only present on p53 molecules which are in a non-DNA-binding conformation . Additionally, it can convert p53 from a DNA-binding conformation to a non-binding conformation, resulting in p53 dissociation from DNA (Halazonetis and Kandil, 1993) .
Because of the complex nature of the interactions between p53 and PAb1620, we chose to use a highly diverse (1.5610 10 members) phage-displayed library of random 40 amino acid peptides. Peptides of 40 amino acids provide several advantages over shorter peptides. They may be long enough to assume secondary structures independent of the gene III protein, and should be long enough to provide multiple contact sites for recognition and binding of complex surfaces, such as presented by receptors and conformational antibodies.
Longer peptides can also be considered to contain multiple shorter peptides or epitopes, with our library containing the equivalent of 3610 11 10-mer peptides.
This library also has a great potential for forming disul®de bonds, and potentially contains 2610 9 disul®de bonded peptides, of which 8610 7 could contain loops of exactly ten amino acids.
This library provided us with three unique peptides which have sequence similarities to p53. One of these peptides is 40 amino acids in length (Clone W), while the other two are signi®cantly shorter at 27 amino acids (Clone 13) and 23 amino acids (Clone 16). Each of these peptides is speci®c for PAb1620 and the synthetic form of one (Clone 13) binds PAb1620 with micromolar anity. The anities of the other two clones has not yet been determined. A preliminary comparison of the peptide sequences with that of p53 revealed no linear sequence identities greater than three amino acids in length, although there is statistically signi®cant sequence identity between the peptides and p53 (Figure 4) .
The p53 site at which PAb1620 binds and exerts its allosteric eects appears to be composed of two regions, residues 106 ± 114 and 146 ± 156. This does not exclude the possibility that other p53 residues bind to this antibody, but they were not detected by this panning eort. Thus, the antibody most likely has two surfaces complementary to these two p53 regions. It appears that the peptides from phage display bind to either or both surfaces, or parts of them. Two phage clones (16 and W, Figure 4 ) seem to be binding to both surfaces, while the third (Clone 13) appears to bind to only one. It can be shown by molecular modeling that the sequences of peptides from Clones 16 and W can be threaded through the crystal structure of p53, while the overlap of the homologous residues is maintained, supporting the idea that the peptides from phage display mimic the structure of p53 when bound to PAb1620.
The location of the PAb1620 binding site on p53 has been previously estimated as being within residues 88 ± Figure 6 Position of the PAb1620 epitope within the structure of p53. The structure of the monomer p53 molecule in the complex with DNA is shown. The ®gure is based on the PDB ®le 1TUP. The structure of the monomer B and one turn of the DNA helix only are shown. The highlighted regions, residues 106 ± 113 and 146 ± 156, comprise the epitope recognized by PAb1620 109 of p53 by based on the epitope for PAb246 (Wade-Evans and Jenkins, 1985; Yewdell et al., 1986) and the cross-blocking between PAb1620 and PAb246 in immunoprecipitation experiments (Milner et al., 1987; reviewed in Lane et al., 1996) . While the results of the present work do not contradict the previous study, the only amino acids identi®ed in common are S106 and Y107. Additionally, this study adds a new region to the recognition site, comprising residues 146 ± 156 of p53.
One mutant form of human p53 containing a single amino acid change (Arg156?Pro) within the region predicted to interact with PAb1620 is of particular interest. The mutation was identi®ed in the human osteosarcoma cell line HOS-SL (Romano et al., 1989) . Detailed analysis of this p53 mutant (Niewolik et al., 1995) shows that it is the only one of thirteen tumorline derived p53 mutants examined that is not immunoprecipitated by PAb1620. The other cell lines in this panel contain single p53 mutations outside of the proposed PAb1620 epitope. These data imply an important role for Arg156 in the binding of p53 to PAb1620, and support our identi®cation of an epitope that contains this residue.
PAb1620 is known to bind to wild-type p53 and induce a conformational shift in p53, such that p53 complexed with PAb1620 loses its ability to bind to DNA . The knowledge of the PAb1620 binding site allows one to formulate a hypothesis as to the mechanism for the conformational change. One of the main DNA binding regions in p53 involves the tip of the L1 loop (residues 112 ± 124 (Cho et al., 1994) ), of which Lys120 interacts directly with DNA (see Figure 6 ). The L1 loop is a direct extension of one region recognized by PAb1620 (residues 106 ± 113) and an indirect extension of the second region (residues 146 ± 156) through the S2-S2' b hairpin (residues 124 ± 141). Thus, structural changes introduced by PAb1620 in its p53 binding site, such as the relative position of the two parts of the binding site, can be transmitted to the tip of the L1 loop by a sort of a`reins' mechanism, and reduce the anity of p53 for its target DNA.
One could also envision that conformational changes in p53 induced by PAb1620 binding might be similar to the structural changes induced by single amino acid substitutions in the PAb1620 binding region. Such mutant forms of p53 have been identi®ed in various tumors (Hainaut et al., 1997) , implying a loss of p53 ability to regulate the cell cycle.
These results show that a suciently diverse library of large peptides can identify the epitope for a conformational antibody, and can provide information about complex allosteric and conformationdependent interactions. Such an approach easily could be applied to investigations of other allostericallyregulated proteins and to other conformation-dependent protein-protein interfaces.
Materials and methods
Phage preparation
Bacterial cells containing phagemid were grown to O.D. 600 =0.5 in 2xYT-AG (yeast tryptone medium containing 100 mg/ml ampicillin and 2% glucose) at 378C with shaking (250 r.p.m.). MK13K07 helper phage was then added (MOI[multiplicity of infection]=15), and the cells were incubated for 30 min at 378C with gentle shaking. Following infection, cells were pelleted and the supernatant containing the helper phage was discarded. The cell pellet was resuspended in the initial culture volume of 2xYT-A (no glucose) containing 50 mg/ml kanamycin and grown overnight at 308C with shaking (250 r.p.m.). The cells from the overnight culture were pelleted at 3000 g for 30 min at 48C and the supernatant containing the phage was recovered. The solution was adjusted to 4% PEG (polyethylene glycol), 500 mM NaCl and chilled on ice for 1 h. The precipitated phage were pelleted by centrifugation at 10 000 g for 30 min. The pellet was resuspended in PBS (phosphate buered saline) containing 2% non-fat dried milk (MPBS).
Microtiter plate preparation
A standard method was used to coat and block all microtiter plates. The target protein of interest was diluted to 1 mg/ml in 50 mM sodium carbonate buer, pH 9.5. One hundred microliters of this solution was added to an appropriate number of wells in a 96-well microtiter plate (MaxiSorp plates, Nunc) and incubated overnight at 48C. Wells were then blocked with MPBS at room temperature for 1 h.
Electrocompetent cell preparation
An overnight culture of E. coli TG1 cells (F,traD36
.05 ± 0.1 in 500 ml 2xYT, then grown at 378C in 4 liter Ehrlenmyer¯asks to an O.D. 600 =0.5 ± 0.6. The culture was poured into pre-chilled centrifuge bottles and incubated on ice for 30 min prior to centrifugation at 2000 g for 30 min (28C). The supernatant was poured o, and the cell pellet was resuspended in a total of 400 ml of ice cold sterile distilled water. The process of centrifugation and resuspension was repeated two more times. After the last centrifugation, the pellet was resuspended in a total of 25 ml of ice cold water containing 10% glycerol. The cell suspension was transferred to pre-chilled 35 ml centrifuge bottles, and was then pelleted at 2000 g for 10 min at 48C. The cells were then suspended in 0.3 ml of the same 10% glycerol solution, aliquoted into smaller tubes, and snapfrozen on dry ice. The aliquots were stored at 7808.
Library construction
DNA fragments coding for peptides containing 40 random amino acids were generated in the following manner. A 145 base oligonucleotide was synthesized to contain the sequence (NNK) 40 , where N=A, C, T, or G, and K=G or T (Figure 1 ). This oligonucleotide was used as the template in a PCR ampli®cation along with two shorter oligo primers, both of which were biotinylated at their 5' ends. The resulting 190 bp (base pair) product was digested with S®I and NotI. Streptavidin-agarose (GIBCO) was added to the digestion mixture to remove the cleaved ends of the PCR product as well as any uncut DNA. The resulting 150 bp fragment was again puri®ed over QIAquick spin columns.
The phagemid pCANTAB5E (Pharmacia) was digested with S®I and NotI, followed by phosphatase treatment. The digested DNA was puri®ed using a 1% agarose gel followed by QIAEX II (Qiagen). The vector and insert were ligated overnight at 158C. The ligation product was puri®ed using QIAquick spin columns (Qiagen) and electroporations were performed at 1500 volts in an electroporation cuvette (0.1 mm gap; 0.5 ml volume) containing 12.5 mg of DNA and 500 ml of TG1 electrocompetent cells. Immediately after the pulse, 12.5 ml of pre-warmed (408C) 2xYT medium containing 2% glucose (2xYT-G) was added and the transformants were grown at 378C for 1 h. Cell transformants were pooled, the volume measured, and an aliquot was plated onto 2xYT-G containing 100 mg/ml ampicillin (2xYT-AG) plates to determine the total number of transformants. Sequence analysis of randomly selected clones indicated that 54% of all clones are in-frame .
Library ampli®cation
Total transformants were inoculated into four liters of 2xYT-AG medium and allowed to grow until the A 600 increased approximately 400 times. The cells were pelleted by centrifugation at 3000 g for 20 min, then resuspended in 40 ml 2xYT-AG to which glycerol was added to a ®nal concentration of 8%. The library was stored at 7808C. This library has been given the name RapidLib TM .
Library phage rescue
This process was carried out using the standard phage preparation protocol (above) with the following changes. Five individual recombinant cell libraries, with a total diversity of 1.5610 10 , were combined and grown to O.D. 600 =0.5 in 2xYT-AG at 308C with shaking (250 r.p.m.). Helper phage (M13K07) was then added (MOI=15), and the cells were incubated for 30 min at 378C with shaking (250 r.p.m.), followed by 30 min at 378C without shaking. The precipitated phage pellet was resuspended in phosphate-buered saline (1/100 of the initial culture volume) and passed through a 0.45 mm ®lter. The phage were titered by infecting TG1 cells. The phage titer was 4610 13 c.f.u./ml.
Panning
Microtiter wells were coated with PAb1620 (Calbiochem) as described above, with eight wells being used for each round of panning. The phage were incubated with MPBS for 30 min at room temperature, then 100 ml was added to each well. For the ®rst round, the input phage titer was 4610 13 c.f.u./ml. For Rounds 2 and 3, the input phage titer was approximately 10 11 c.f.u./ml. Phage were allowed to bind for 2 ± 3 h at room temperature. The wells were then quickly washed 13 times with 200 ml/well of MPBS. Bound phage were eluted by incubation with 100 ml/well of 20 mM glycine-HCl, pH 2.2 for 30 s. The resulting solution was then neutralized with Tris-HCl, pH 8.0. Log phase TG1 cells were infected with the eluted phage, then plated onto two 20 cm620 cm plates containing 2xYT-AG. The plates were incubated at 308C overnight. The next morning, cells were removed by scraping and stored in 10% glycerol at 7808C. For subsequent rounds of anity enrichment, cells from these frozen stocks were grown and phage were prepared as described above.
ELISA analyses of phage
For phage pools, cells from frozen stocks were grown and phage were prepared as described above. For analysis of individual clones, colonies were picked and phage prepared as described above. Subsequent steps are the same for pooled and clonal phage. Microtiter wells were coated and blocked as described above. Wells were coated with either PAb1620 or a control IgG MAb. Phage resuspended in MPBS were added to duplicate wells (100 ml/well) and incubated at room temperature for 1 h. The phage solution was then removed, and the wells were washed three times with PBS at room temperature. Anti-M13 antibody conjugated to horseradish peroxidase (Pharmacia Biotech) was diluted 1 : 3000 in MPBS and added to each well (100 ml/well). Incubation was for another hour at room temperature, followed by PBS washes as described. Color was developed by addition of ABTS solution (100 ml/well; Boehringer). Color development was stopped by adjusting each well to 0.5% SDS. Plates were analysed at 405 nm using a SpectraMax 340 plate reader (Molecular Devices) and SoftMax Pro software. Data points were averaged after subtraction of appropriate blanks. A clone was considered`positive' if the A 405 of the well was 5twofold over background.
Competition ELISAs
For IC 50 determinations, microtiter plates were coated with PAb1620 and blocked as described. Phage were prepared as described. Prior to addition of phage to plates, synthetic Clone 13 peptide (or a control peptide) was diluted in PBS and added to duplicate wells (100 ml/well). After incubation for 1 h at room temperature, the prepared phage were added to each well (100 ml/well) without removing the peptide solution. After incubation for another hour at room temperature, the wells were washed and the color developed as described above.
Peptide synthesis
Synthetic peptides were obtained from a commercial supplier (Anaspec). The peptides were supplied greater than 90% pure by HPLC. The molecular weights of the peptides as determined by mass spectroscopy agreed with the expected values.
BIAcore analysis
Monoclonal antibody PAb1620 was immobilized onto onē ow-cell of a CM-5 sensor chip (Biosensor) using amine coupling chemistry and the manufacturer's recommended protocol. An unrelated IgG was immobilized in the same manner to another¯ow cell of the same chip as a control surface. Increasing concentrations of the synthetic Clone 13 peptide were injected over both surfaces, and the binding responses were allowed to come to equilibrium. After subtraction of background binding (from the control surface), the results were used to derive an equilibrium dissociation constant using Scatchard analysis. The reported apparent K D value (3.5 mM) is the average of three independent experiments using dierent amounts of immobilized PAb1620.
